Hereditary risk factors for the development of gastric cancer in younger patients by Yaghoobi, Mohammad et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Gastroenterology
Open Access Research article
Hereditary risk factors for the development of gastric cancer in 
younger patients
Mohammad Yaghoobi*, Naser Rakhshani, Farhad Sadr, Raheleh Bijarchi, 
Yasamin Joshaghani, Ashraf Mohammadkhani, Arezou Attari, 
Mohammad Reza Akbari, Mahshid Hormazdi and Reza Malekzadeh
Address: Digestive Disease Research Center, Tehran University of Medical Sciences, Shariati Hospital, Kargar Shomali St, Tehran 14114, Iran
Email: Mohammad Yaghoobi* - yaghoobi@ams.ac.ir; Naser Rakhshani - rakhshani@ddrcir.org; Farhad Sadr - sadr_ddrcir@yahoo.com; 
Raheleh Bijarchi - rahelehbi@yahoo.com; Yasamin Joshaghani - joshaghani_ddrcir@yahoo.com; 
Ashraf Mohammadkhani - mohammadkhani@ddrcir.org; Arezou Attari - attari1382@yahoo.com; Mohammad Reza Akbari - akbari@ddrcir.org; 
Mahshid Hormazdi - hormozdi_ddrc@yahoo.com; Reza Malekzadeh - malek@ams.ac.ir
* Corresponding author    
Abstract
Background: It is believed that the development of gastric cancer (GC) before the age of 50 has
a hereditary basis. Blood group A and history of gastric cancer in first-degree relatives have been
shown to be risk factors for GC.
Methods: In this case-control study, we enrolled patients with GC who were diagnosed before
the age of 50. Patients who were diagnosed as having GC were selected. A total of 534 cases were
found; of these, 44 diagnosed before the age of 50 were included in the case group. For the control
group, 22 males and 22 females were randomly selected from the remaining subjects, who had
diagnoses of GC after the age of 50. All the surviving patients and family members of the dead
patients were interviewed about the history of cancer in the family and the age at which other
family members developed cancer. The blood group of each subject was also obtained.
Results: forty-four cases under 50 years old (mean age: 36.2 years) and forty-four controls (mean
age: 67.1 years) were enrolled in the study. At the time of the study, 59.1% of the study group and
50% of the control group were alive (P value = NS). In the study group, 68.1%, 13.6%, 13.6% and
4.5% had blood groups O, A, B and AB, respectively. In the control group the corresponding figures
were 27.7%, 63.6%, 6.8% and 4.5%. First or second-degree relatives with cancer, including gastric
(the most frequent), breast, lung, gynecological and hematological malignancies, were noted in
54.5% of the cases and 11.4% of the controls (p < 0.01). Family histories of cancer were accepted
as valid provided that they were based on valid medical documents.
Conclusions:  It seems that the development of GC before the age of 50 is likely to be
accompanied by familial susceptibility. Interestingly, our study showed a significant correlation
between blood group O and the development of gastric cancer under the age of 50.
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Background
Gastric cancer is the second most common cause of can-
cer-related death in the world [1]. Its incidence varies con-
siderably worldwide [2]. In general, it is a larger problem
in developing countries than in industrialized nations,
and shows a predilection for urban and lower socioeco-
nomic groups [3,4]. The estimated crude rate accounts for
approximately 9.9% of cancers worldwide [5]. Gastric
cancer rarely occurs before the age of 40. The incidence
rises steadily thereafter, peaking in the seventh decade.
Men are nearly twice as susceptible as women. This cancer
alone is the cause of more than 750,000 deaths per
annum in the world [6]. Marked variation within coun-
tries has also been observed [3,4], particularly in high-risk
countries [7]. In developing countries, the overall inci-
dence of gastric cancer is increasing and projections indi-
cate that the annual number of new cases will increase
significantly during the next few decades as a result of
adult population growth [6]. A recent cancer survey by the
Iranian Ministry of Health and Medical Education
revealed that gastric adenocarcinoma is the most common
fatal cancer in Iran, with a wide variation of death rate
among different provinces [8]. According to recent cancer
statistics, deaths due to gastric cancer constitute about
39% of all deaths due to cancer each year in some parts of
Iran [9].
The reduced incidence of gastric cancer in western coun-
tries reflects a decrease in cancers arising in the distal
stomach (body and antrum). In contrast, the incidence of
cancer in the proximal stomach and esophagogastric junc-
tion has steadily increased, at a rate exceeding that of any
other cancer except melanoma and lung cancer [10-13]. In
a very recent study, our group showed that cardiac cancer
constitutes 49.5% of all sites for gastric cancer in Iran. In
contrast, cancers of body and antrum comprise 20.6%
and 29.9% respectively [9]. Unlike cancer of the distal
stomach, cancers of the proximal stomach and esoph-
agogastric junction are more common among higher soci-
oeconomic classes [6]. Overall, these observations suggest
that proximal cancers share a similar pathogenesis, which
is distinct from that of distal cancers. Zanghieri and La
Vecchia found that about 10% of cases show familial clus-
tering. Epidemiological studies have shown that the risk
of gastric cancer in first-degree relatives is increased 2- to
3-fold [14-17]. The relative contributions of inherited sus-
ceptibility and environmental effects on familial gastric
cancer are poorly understood.
In general, familial genetic mechanisms do not play as
important a role in gastric cancer as they do in e.g. color-
ectal cancer. Nonetheless, in some regions, a family his-
tory of gastric cancer may be a risk factor for the disease,
although this might reflect environmental factors shared
by members of a family [18]. Rate collections of familial
aggregates of gastric cancer have been reported, but are
distinctly unusual. As yet there is no comprehensive
hypothesis for the development of gastric cancer. Gastric
cancers are associated with chromosomal aberrations and
other genetic defects, but none of these is necessary or suf-
ficient for cancer to occur.
In a review about genetic predisposition to gastric cancer,
Bevan and Houlston (1999) concluded that several genes
may be associated with increased risk [19]. Gastric cancer
is a manifestation of several inherited cancer predisposi-
tion syndromes including hereditary nonpolyposis colon
cancer, familial adenomatous polyposis, Peutz-Jeghers
syndrome and Cowden disease. This suggests the presence
of predisposing genes with different effects.
Many studies have addressed the correlation between
ABO antigens and the development of gastric cancer, but
most of these have indicated a correlation between spo-
radic cases of gastric cancer and blood group A. This asso-
ciation further supports the role of genetic factors in the
development of gastric cancer [21]. Blood type A is more
strongly associated with the diffuse histopathological type
of gastric cancer than the intestinal type [21,22]. To our
knowledge, similar studies on the specific category of gas-
tric cancer in younger patients are scanty. This may be one
of the first studies on the role of hereditary factors in the
development of the gastric cancer in younger patients.
Methods
The study was designed as a case-control study. We set up
an active surveillance to identify patients with gastric can-
cer. Patients' records in the department of pathology in
the main private referral facility in Tehran were scruti-
nized for gastric cancer cases between 1999 and 2003.
Patients are referred here from all regions of the country
and from different ethnic backgrounds and they are oper-
ated upon in the same hospital, so all the operation and
pathology reports were available simultaneously. All the
pathology reports were prepared and diagnosed by the
same pathologists. The cases were selected from patients
who were diagnosed with gastric cancer before the age of
fifty. The sex-matched controls were randomly selected
and enrolled from patients who were diagnosed over the
age of fifty. All the patients and their family were inter-
viewed regarding the history of gastric or other types of
cancer over three generations, and the blood groups of
affected members were ascertained. Family histories of
cancer were accepted as valid provided that they were
based on valid medical documents. The transfusion
records of the operation were also used to identify the
patients' blood groups.
Statistical analysis was performed using the SPSS Statistical
Package (version 10.0). The quantitative variables wereBMC Gastroenterology 2004, 4:28 http://www.biomedcentral.com/1471-230X/4/28
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expressed as means (minimum-maximum) when appro-
priate. A chi-square test was performed to ascertain the
overall effect of blood group on the development of gas-
tric cancer before the age of 50. All statistical tests were
two-sided and differences at the 0.01 level were consid-
ered statistically significant.
Results
At the beginning of the study, 44 cases (mean age: 36.2,
18–49; m/f = 1) under 50 years old and 44 sex-matched
controls (mean age: 67.1, 50–88) were enrolled. Table 1
shows the pathological characteristics of all 88 subjects. At
the time of the study, 59.1% of the case group and 50% of
the control group were alive; 53.8% of the case group and
38.6% were living in Tehran, but no information on resi-
dence background was available. Data regarding first-
degree relatives were complete for both groups. These data
comprised information on 383 persons in the case group
(average 9.1 for each proband) and 498 in the control
group (average 11.6 for each proband). Table  shows the
distribution of blood groups in the two subject groups.
Gastric (22 cases) and other types of cancer were reported
in 54.5% of the first-degree relatives of the cases and
11.4% of the first-degree relatives of the controls (p <
0.01). The "other types of cancer" among relatives of the
case group comprised colorectal (7 cases), breast (3 cases),
lung (3 cases), gynecological (2 cases), hematological (1
case) and bladder (1 case) malignancies. For the control
group, the corresponding figures were colorectal (2 cases),
breast (1 case), lung (1 case) and prostate (1 case) malig-
nancies. Figures 1, 2, 3 show three pedigrees of familial
connections.
Discussion
This case control study demonstrates that hereditary fac-
tors, especially familial history of cancer and possession
of blood group O, are associated with the development of
gastric cancer under the age of fifty. To our knowledge,
this may be the first study showing a correlation between
blood group O and the development of gastric cancer in a
specific category of patients.
Risk factors for gastric cancers have been explored in a
number of previous studies, including genetic factors such
as blood group. Haenszel et al. suggested an association
between gastric cancer and blood type A, supporting the
view that genetic factors have a role in the development of
gastric cancer [21]. Our study emphasizes the role of
genetic factors in one subcategory of patients, those who
develop gastric cancer under the age of fifty. Blood group
A is more strongly associated with the diffuse histopatho-
logical type of gastric cancer than the intestinal type
[21,22]. In our study, most of the patients had a diffuse
rather than intestinal type, so we could not test this asso-
ciation. A larger sample size would be needed. On the
other hand, there might be a higher prevalence of
Helicobacter pylori in our community, causing a higher
incidence of the diffuse type of gastric cancer. However,
there were no significant differences in histological type of
gastric cancer between the case and control groups. In a
study by Su et al. in 2001, a total of 6685 patients with
esophageal carcinoma and 2955 patients with cardiac
cancer in the Chaoshan district were retrospectively
assessed for their association with ABO blood groups. Su
et al. showed that the distribution of ABO blood groups in
patients with esophageal carcinoma or cardiac cancer was
similar to that in the normal local population, but there
was an association between blood group B and the devel-
opment of cancer of cardia in males [23].
In our study, approximately 54% of the case group had a
familial history of cancer compared to 11% of the control
group. This seems compatible with the findings of a pop-
ulation-based case-control study of stomach cancer in
Warsaw, Poland. Here, the investigators interviewed 464
Table 1: The pathologic characteristics of the tumor in the case and control group (n = 44 in each group).
Pathologic differentiation Pathologic Type Location of the tumor
Case group Well differentiated 1.4% Diffuse 0.5% Cardia 13.6%
Moderately differentiated 5.0% Body 18.2%
Poorly differentiated 1.4% Intestinal 7.3% Distal 68.2%
Control group Well differentiated 7.3% Diffuse 5% Cardia 22.7%
Moderately differentiated 5.0% Body 29.5%
Poorly differentiated 7.7% Intestinal 5% Distal 47.7%
P value NS NS NS
Table 2: Frequency of the different blood groups in the study 
population (n = 44). The figures in parentheses are the number of the 
patients.
Blood group O A B AB
Cases (30) 68.1% (6) 13.6% (6) 13.6% (2) 4.5%
Controls (11) 27.3% (28) 63.6% (3) 6.8% (2) 4.5%
P value <0.05 <0.01 NS NSBMC Gastroenterology 2004, 4:28 http://www.biomedcentral.com/1471-230X/4/28
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cases and 480 controls to evaluate the role of family
history and other risk factors. A greater than threefold
increase in risk was associated with a history of gastric can-
cer in a first degree relative (OR = 3.5), but no excess risk
was seen for other forms of cancer. The risk associated
with familial occurrence was not significantly modified by
gender, age or ABO blood type, and did not vary with Lau-
ren histological classification24. Despite the relatively
large sample size in the Polish study, younger patients
were not evaluated as a separate category. This may
explain the difference between their results and ours. Fur-
thermore, they defined "positive family history" as having
a first-degree relative with gastric cancer. In contrast, we
considered all types of malignancy in first and second-
degree relatives; though the familial incidence of other
(non-GI) malignancies in our study may reflect their
higher frequency in the community rather than any
genetic risk factor. The Polish study did not confirm pre-
vious results on the correlation between blood group A
and gastric cancer. Moreover, another study by Parsonnet
et al on 90 cases and 89 controls showed no association
between ABO blood group and malignancy [25]. In a
multicentric study in Italy, 1016 patients with gastric can-
cer and 1623 population controls were interviewed to
determine family histories of gastric, esophageal and
colorectal cancer. A significant association was found with
history of gastric cancer in a sibling or parent (odds ratios
2.6 and 1.7, respectively). Among the adult siblings of
controls and cases, the prevalences of gastric cancer
reported at interview were 1 and 2.7%, respectively. A fur-
ther increase was noted in families with at least one
affected parent (1.4 and 5.7%). The risk of gastric cancer
A family with aggregation with gastric cancer (GC: Gastric Cancer; Ca: History of gastric cancer but not confirmed by a patho- logic reports for the histologic type of cancer) Figure 1
A family with aggregation with gastric cancer (GC: Gastric Cancer; Ca: History of gastric cancer but not confirmed by a patho-
logic reports for the histologic type of cancer).BMC Gastroenterology 2004, 4:28 http://www.biomedcentral.com/1471-230X/4/28
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associated with a positive family history was greater
(increased about 2-fold) among residents of low-risk
areas. Among the cases, there was no relationship between
family history of gastric cancer and blood group A or his-
tological type according to the Lauren classification [26].
In our study, there was no significant relationship
between the histological type of the cancer and positive
family history or blood group. However, this does not
prove that the two variables do not correlate; an associa-
tion might become apparent with a larger study. Mecklin
et al studied the clinical and histopathological character-
istics of gastric carcinoma in young patients (under 40
years old) in Finland in 1988. In 94% of the young
patients, the carcinoma was of the diffuse type. They
showed a poor prognosis, an equal sex ratio, and a strong
association with blood group A in their study group. They
also found a highly significant over-representation of gas-
tric cancer in the parents of the index cases (p < 0.001)
[27]. The difference between Mecklin's study and ours in
the blood groups identified as risk factors may reflect eth-
nic differences; both studies confirm a significant correla-
tion between a specific blood group and the development
of gastric cancer. Future studies may use linkage analysis
to detect genetic abnormalities in chromosomal regions
that are located near the genes encoding the ABO
antigens.
Matching the geographical origins of the cases and con-
trols could have improved the power of our study by
excluding ethnic factors from the study population. How-
ever, this is very difficult to achieve in such studies
because there is a high rate of combinations between races
in the country. In addition, the sample size was too small
for such effects to be excluded. However, there were no
significance differences between the two groups in respect
of the origins of the subjects.
In conclusion, our results show that familial history of
cancer, and hereditary factors including blood group,
have a role in the development of gastric cancer in young
patients. The role of environmental factors may be more
A family with a history of the aggregation with Colorectal cancer (GC: Gastric Cancer; CRC: Colorectal Cancer; PLP: Color- ectal Polyps; Numbers in circles: Current age of the persons; CAG: Chronic Active Gastritis) Figure 2
A family with a history of the aggregation with Colorectal cancer (GC: Gastric Cancer; CRC: Colorectal Cancer; PLP: Color-
ectal Polyps; Numbers in circles: Current age of the persons; CAG: Chronic Active Gastritis).BMC Gastroenterology 2004, 4:28 http://www.biomedcentral.com/1471-230X/4/28
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important in older patients and can be considered in
future studies.
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